Rhynexa is a Basel-based biotechnology venture working in the area of MSC-based cell therapy.
We focus on improving product quality, reproducibility, and functional characterization to support more consistent and translation-ready MSC therapy development.
Rhynexa is currently in the proof-of-concept stage and is building a structured experimental program around MSC product variability, potency assessment, and scalable development workflows.
We are open to selected collaborations with academic host labs, core facilities, and translational partners in Basel and beyond.

Rhynexa GmbH

Org chart

Teams

Offices

Rhynexa GmbH

Org chart

Teams

Offices

Related companies